The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia

Abstract Background Noncoding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are becoming key parts in the development of multidrug resistance (MDR) in T-cell acute lymphoblastic leukemia (T-ALL). Abnormal expression in sialyated N-glycans have been observed in MDR leukemia. H...

Full description

Bibliographic Details
Main Authors: Qianqian Liu, Hongye Ma, Xiuhua Sun, Bing Liu, Yang Xiao, Shimeng Pan, Huimin Zhou, Weijie Dong, Li Jia
Format: Article
Language:English
Published: BMC 2019-05-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13046-019-1208-x
id doaj-67c94db87f8d41b6adfd4397ea155de0
record_format Article
spelling doaj-67c94db87f8d41b6adfd4397ea155de02020-11-25T02:59:10ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662019-05-0138111510.1186/s13046-019-1208-xThe regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemiaQianqian Liu0Hongye Ma1Xiuhua Sun2Bing Liu3Yang Xiao4Shimeng Pan5Huimin Zhou6Weijie Dong7Li Jia8College of Laboratory Medicine, Dalian Medical UniversityDepartment of Clinical Laboratory, Beijing Hospital of Traditional Chinese Medicine Affiliated to Capital University of Medicine SciencesDepartment of Medicine Oncology, Second Affiliated Hospital of Dalian Medical UniversityCollege of Laboratory Medicine, Dalian Medical UniversityCollege of Laboratory Medicine, Dalian Medical UniversityCollege of Laboratory Medicine, Dalian Medical UniversityDepartment of Microbiology, Dalian Medical UniversityDepartment of Biochemistry, Dalian Medical UniversityCollege of Laboratory Medicine, Dalian Medical UniversityAbstract Background Noncoding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are becoming key parts in the development of multidrug resistance (MDR) in T-cell acute lymphoblastic leukemia (T-ALL). Abnormal expression in sialyated N-glycans have been observed in MDR leukemia. However, the role of sialylation regulated MDR remains poorly understood. The aim of this work is to analyze the alternation of N-glycans in T-ALL MDR. Methods Here, mass spectrometry (MS) is analyzed to screen the N-glycan profiles from ALL cell line CR and adriamycin (ADR)-resistant CR (CR/A) cells. The expression of sialyltransferase (ST) genes in T-ALL cell lines and bone marrow mononuclear cells (BMMCs) of T-ALL patients were analyzed using qRT-PCR. Functionally, T-ALL cell proliferation and MDR are detected through CCK8 assay, colony formation assay, western blot and flow cytometry. RIP assay and Dual-luciferase reporter gene assay confirm the binding association between ZFAS1 and miR-150. Xenograft nude mice models are used to determine the role of ST6GAL1 in vivo. Results Elevated expression of α2, 6-sialyltransferase 1 (ST6GAL1) has been detected. The altered level of ST6GAL1 was corresponding to the drug-resistant phenotype of T-ALL cell lines both in vitro and in vivo. ZFAS1/miR-150/ST6GAL1 axis was existed in T-ALL cell lines. MiR-150 was downregulated and inversely correlated to ST6GAL1 expression. ZFAS1 was a direct target of miR-150 and positively modulated ST6GAL1 level by binding miR-150. ZFAS1/miR-150/ST6GAL1 axis functioned to regulate ADR-resistant cell growth and apoptosis. Besides, EGFR was demonstrated to be a substrate of ST6GAL1, and the sialylated EGFR had an impact on the PI3K/Akt pathway. Conclusion Results suggested that ZFAS1/miR-150/ST6GAL1 axis involves in the progression of T-ALL/MDR further mediates sialylated EGFR via PI3K/Akt pathway. This work might have an application against T-ALL MDR.http://link.springer.com/article/10.1186/s13046-019-1208-xT-ALLST6GAL1miR-150ZFAS1EGFR/PI3K/Akt pathway
collection DOAJ
language English
format Article
sources DOAJ
author Qianqian Liu
Hongye Ma
Xiuhua Sun
Bing Liu
Yang Xiao
Shimeng Pan
Huimin Zhou
Weijie Dong
Li Jia
spellingShingle Qianqian Liu
Hongye Ma
Xiuhua Sun
Bing Liu
Yang Xiao
Shimeng Pan
Huimin Zhou
Weijie Dong
Li Jia
The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia
Journal of Experimental & Clinical Cancer Research
T-ALL
ST6GAL1
miR-150
ZFAS1
EGFR/PI3K/Akt pathway
author_facet Qianqian Liu
Hongye Ma
Xiuhua Sun
Bing Liu
Yang Xiao
Shimeng Pan
Huimin Zhou
Weijie Dong
Li Jia
author_sort Qianqian Liu
title The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia
title_short The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia
title_full The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia
title_fullStr The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia
title_full_unstemmed The regulatory ZFAS1/miR-150/ST6GAL1 crosstalk modulates sialylation of EGFR via PI3K/Akt pathway in T-cell acute lymphoblastic leukemia
title_sort regulatory zfas1/mir-150/st6gal1 crosstalk modulates sialylation of egfr via pi3k/akt pathway in t-cell acute lymphoblastic leukemia
publisher BMC
series Journal of Experimental & Clinical Cancer Research
issn 1756-9966
publishDate 2019-05-01
description Abstract Background Noncoding RNAs, including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) are becoming key parts in the development of multidrug resistance (MDR) in T-cell acute lymphoblastic leukemia (T-ALL). Abnormal expression in sialyated N-glycans have been observed in MDR leukemia. However, the role of sialylation regulated MDR remains poorly understood. The aim of this work is to analyze the alternation of N-glycans in T-ALL MDR. Methods Here, mass spectrometry (MS) is analyzed to screen the N-glycan profiles from ALL cell line CR and adriamycin (ADR)-resistant CR (CR/A) cells. The expression of sialyltransferase (ST) genes in T-ALL cell lines and bone marrow mononuclear cells (BMMCs) of T-ALL patients were analyzed using qRT-PCR. Functionally, T-ALL cell proliferation and MDR are detected through CCK8 assay, colony formation assay, western blot and flow cytometry. RIP assay and Dual-luciferase reporter gene assay confirm the binding association between ZFAS1 and miR-150. Xenograft nude mice models are used to determine the role of ST6GAL1 in vivo. Results Elevated expression of α2, 6-sialyltransferase 1 (ST6GAL1) has been detected. The altered level of ST6GAL1 was corresponding to the drug-resistant phenotype of T-ALL cell lines both in vitro and in vivo. ZFAS1/miR-150/ST6GAL1 axis was existed in T-ALL cell lines. MiR-150 was downregulated and inversely correlated to ST6GAL1 expression. ZFAS1 was a direct target of miR-150 and positively modulated ST6GAL1 level by binding miR-150. ZFAS1/miR-150/ST6GAL1 axis functioned to regulate ADR-resistant cell growth and apoptosis. Besides, EGFR was demonstrated to be a substrate of ST6GAL1, and the sialylated EGFR had an impact on the PI3K/Akt pathway. Conclusion Results suggested that ZFAS1/miR-150/ST6GAL1 axis involves in the progression of T-ALL/MDR further mediates sialylated EGFR via PI3K/Akt pathway. This work might have an application against T-ALL MDR.
topic T-ALL
ST6GAL1
miR-150
ZFAS1
EGFR/PI3K/Akt pathway
url http://link.springer.com/article/10.1186/s13046-019-1208-x
work_keys_str_mv AT qianqianliu theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT hongyema theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT xiuhuasun theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT bingliu theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT yangxiao theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT shimengpan theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT huiminzhou theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT weijiedong theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT lijia theregulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT qianqianliu regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT hongyema regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT xiuhuasun regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT bingliu regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT yangxiao regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT shimengpan regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT huiminzhou regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT weijiedong regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
AT lijia regulatoryzfas1mir150st6gal1crosstalkmodulatessialylationofegfrviapi3kaktpathwayintcellacutelymphoblasticleukemia
_version_ 1724703924119666688